Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Pharmacogenomics: Identification of New Drug Targets
Atherosclerosis III: Management
Pleiotropy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Sanjay Bhandari1, Pankaj Gupta2, Paulene Quinn1
1Department of Cardiovascular Sciences, University of Leicester, Leicester, UK; NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, University of Leicester, Leicester, UK.

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
10:56A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
在PubMed 上查看摘要
类药物改变脂蛋白载荷,影响细胞骨组织,炎症和抗氧化防御. 这项研究揭示了他类药物诱导的素降低和糖尿病风险之间的潜在联系.
科学领域:
背景情况:
研究的目的:
主要方法:
主要成果:
结论: